RYR2 and catecholaminergic polymorphic ventricular tachycardia 1: These findings demonstrate that iPSC-CMs are useful for investigating the similarities/differences in the pathophysiological consequences of RyR2 versus CASQ2 mutations underlying CPVT1 and CPVT2 syndromes, respectively.